Robert Topp, RN, PhD Abstract This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches
Discontinue use if nausea, abdominal discomfort, diarrhea, or another unwanted reaction occurs
Materials and Methods Study Design and Setting This retrospective study utilized prospectively collected data from patients treated at our bariatric surgery center between January 2019 and October 2023
If the next step affects treatment or sourcing, use the article to prepare questions for a licensed clinician
It has been studied for sleep, opioid and alcohol withdrawal, stress, and pain modulation
Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface